(Q41404345)

30 September 2017

title

Effect of dichloroacetate on the exercise performance of patients with heart failure (English)

1 reference

30 September 2017

0 references

J R Wilson

1

1 reference

30 September 2017

D M Mancini

series ordinal

2

1 reference

30 September 2017

N Ferraro

series ordinal

3

1 reference

30 September 2017

J Egler

series ordinal

4

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 December 1988

1 reference

Journal of the American College of Cardiology

30 September 2017

published in

1 reference

30 September 2017

volume

12

1 reference

30 September 2017

issue

6

1 reference

30 September 2017

page(s)

1464-1469

1 reference

Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle.

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Activation of pyruvate dehydrogenase in perfused rat heart by dichloroacetate (Short Communication).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Prolonged hypolactatemia and increased total pyruvate dehydrogenase activity by dichloroacetate

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Dichloroacetate: Effects on exercise endurance in untrained rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Effect of dichloroacetate on plasma lactic acid in exercising dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Treatment of lactic acidosis with dichloroacetate

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Metabolic Effects of Dichloroacetate in Patients with Diabetes Mellitus and Hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Leg Blood Flow during Exercise in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Glucose metabolism in perfused skeletal muscle. Pyruvate dehydrogenase activity in starvation, diabetes and exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Active and inactive forms of pyruvatedehydrogenase in skeletal muscle as related to the metabolic and functional state of the muscle cell

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Lactate extraction during net lactate release in legs of humans during exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Lactate release in relation to tissue lactate in human skeletal muscle during exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

It is diprotonated inorganic phosphate that depresses force in skinned skeletal muscle fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Relationship of muscular fatigue to pH and diprotonated Pi in humans: a 31P-NMR study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Circulatory improvement after hydralazine or isosorbide dinitrate administration in patients with heart failure. Effect on metabolic responses to submaximal exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Metabolic assessment of exercise in chronic heart failure patients treated with short-term vasodilators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Long-Term Vasodilator Therapy with Trimazosin in Chronic Cardiac Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

Exercise responses before and after long-term treatment with oral milrinone in patients with severe heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2888%2980010-X

7 January 2021

10.1016/S0735-1097(88)80010-X

Identifiers

DOI

1 reference

30 September 2017

1 reference